2 completed, 1 terminated. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Analgesics: new trials by email Literature Review of Analgesics trials Research Report on Analgesics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder Lemborexant, Placebo, Buprenorphine-naloxone - Drug Interaction, Analgesics | Phase 1 / Phase 2 | Completed | Virginia Commonwealth University | 18 | 2021-05-03 | 2024-11-13 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 CYNK-001 - Coronavirus, Coronavirus Infection | Phase 1 / Phase 2 | Terminated | Celularity Incorporated | 7 | 2020-09-02 | 2026-06-26 |
| Mentholated Cream Containing Oxygenated Glycerol Triesters on Acute Pain of the Muscles and Joints Mentholated Cream, Mentholated Cream with OGT - Pain, Analgesics | Phase 1 / Phase 2 | Completed | NEMA Research, Inc. | 71 | 2007-05-01 | 2011-07-06 |
Acute Pain (1) · COVID-19 (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Immune System Diseases (1) · Lung Diseases (1) · Musculoskeletal Pain (1) · Nidovirales Infections (1) · Opioid-Related Disorders (1) · Pain (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Chemically-Induced Disorders (1) · Infections (1) · Mental Disorders (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Narcotic-Related Disorders (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Substance-Related Disorders (1)
Buprenorphine, Naloxone Drug Combination (1) · UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase (1) · lemborexant (1)
Celularity Incorporated (1) · NEMA Research, Inc. (1) · Virginia Commonwealth University (1)
United States (2)
Barry T Reece, MS, MBA (1) · Corey Casper, MD MPH (1) · Frederick G Moeller, MD (1) · Jessica Williams, BS (1)
UG1DA050207 (1)